Understanding how a protein regulates calcium signaling and lipid metabolism in Alzheimer's disease

Regulation of intracellular calcium signaling and phosphoinositide metabolism by IRBIT

NIH-funded research Bates College · NIH-10702168

This study is looking at how a protein called IRBIT influences important processes related to calcium and fat in cells, which could help us understand Alzheimer's disease better and find new ways to treat it.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionBates College NIH-funded
Lab location1 site (Lewiston, United States)
Project IDNIH-10702168 on NIH RePORTER

What this research studies

This research investigates the role of a protein called IRBIT in regulating calcium signaling and lipid metabolism, which are crucial processes in Alzheimer's disease and related conditions. By using human embryonic kidney cells, the researchers will analyze how IRBIT affects these signaling pathways through various techniques, including lipid mass spectrometry and live-cell imaging. The goal is to uncover the molecular mechanisms that contribute to Alzheimer's disease, potentially leading to new therapeutic targets.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals affected by Alzheimer's disease or related neurological conditions.

Not a fit: Patients with conditions unrelated to Alzheimer's disease or those who do not have neurological disorders may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new insights and treatments for Alzheimer's disease and related neurological disorders.

How similar studies have performed: While the specific approach of studying IRBIT is novel, similar research has shown promise in understanding calcium signaling and lipid metabolism in neurological diseases.

Where this research is happening

Lewiston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.